Acne

  • Cover Story
    Acne & Rosacea Review
    Fri, 02/03/2012 - 12:25

    An update on recent news, research and treatment trends for acne and rosacea.

    A new study shows that combination light and thermal treatment for acne may lead to improved clinical outcomes, and a trial of isotretinoin for rosacea reveals that higher doses may be the key to treatment success.

    Read the full story
  • Laser & Light Therapies in Practice
    New FDA Approvals, Treating Acne Scars and More
    Fri, 11/04/2011 - 10:25

    This ongoing series examines recent news and updates about laser and light therapies. This month's edition covers the recent announcement by Medicis Technologies Corporation (formerly LipoSonix, Inc.), a subsidiary of Medicis Pharmaceutical Corporation, that they have received FDA clearance for the second generation LipoSonix system, indicated for non-invasive waist circumference reduction, a new study reveals that a combination laser approach is effective for the treatment of acne scars and more.

    Read the full story
  • Online Exclusive
    A Review of Recent Isotretinoin Studies
    Mon, 09/12/2011 - 10:27

    Two recent studies examine the safety and efficacy of this acne treatment. The first, from researchers at NorthShore University Health System in Evanston, IL, and the UNC Chapel Hill Department of Dermatology, aimed to determine if higher cumulative doses of isotretinoin would result in fewer incidences of treatment failure. The second, from a team at UC San Diego School of Medicine, evaluates the use of a patient symptom survey for monitoring and treating side effects related to isotretinoin.

    Read the full story
  • Feature
    Acne and Rosacea Review
    Fri, 09/09/2011 - 10:21

    A review of recent studies, news and trends related to acne and rosacea, including a look at two separate studies that link stress to the worsening of skin conditions.

    Read the full story
  • The Cosmetic Clinic
    Dealing with Scars
    Thu, 08/11/2011 - 13:10

    While prevention - especially in the case of acne - is best, there are effective treatments available to minimize or eliminate scars.

    Read the full story
  • New Products
    New Products
    Wed, 08/10/2011 - 13:18

    A review of new products for sun protection, acne, cosmetic dermatology, and more.

    Read the full story
  • Cover Story
    15 Acne Myths Addressed
    Wed, 06/01/2011 - 13:22

    Dispelling common myths about the causes and treatment of acne can make all the difference in how acne patients view themselves and others who suffer from this all-too-common and distressing medical condition.

    Acne is the most common condition that dermatologists treat. While assessing which acne treatment is appropriate for a patient, it is valuable to consider the beliefs — the mythology if you will — of patients regarding acne.

    Read the full story
  • Helpful Handouts
    Acne
    Wed, 05/04/2011 - 10:46

    This month’s handout from Drs. Danby and Margesson takes on acne, a topic Dr. Danby recently discussed in “Treatment Strategies for Acne” in the book Treatment Strategies – Dermatology.

    Read the full story
  • Feature
    Acne and Rosacea Review
    Wed, 05/04/2011 - 09:13

    An update of the latest research and trends.

    Trial Finds Vicept’s V-101 Cream Safe and Effective for Erythematotelangiectatic Rosacea

    Read the full story
  • PAs in Practice
    Product Selection and Dispensing in a New Health Care Era
    Thu, 03/31/2011 - 11:26

    With healthcare reform knocking on our doors, prescription formularies becoming more limited, and branded prescription medications too expensive for many of our patients, dispensing products out of the office and private labeling is becoming more and more commonplace.

    Read the full story
  • New Products
    New Products
    Thu, 03/31/2011 - 10:14

    New Products
    P 46

    DNA Scar Therapy Improves Appearance of Scars

    According to a press release from DNA EGF Renewal, its DNA Scar Therapy uses a combination of enzymes, silicone, sunflower seed oil and beta glucan to speed up the healing process and make scars appear smoother and less noticeable.

    Read the full story
  • New Products
    New Products
    Tue, 03/01/2011 - 15:07

    Clinically Proven Stretch Mark Creams From Mustela

    A new “Stretch Marks Survival Set” from Mustela contains paraben-free, phthalate-free and phenoxyethanol-free products for use during and after pregnancy.

    A company-issued press release on the two products made the following claims.

    Read the full story
  • FDA Approvals and News
    News & Trends
    Wed, 02/02/2011 - 16:29

    News & Trends

    P. Acnes Suspected as Cause of Some Infections

    Read the full story
  • Feature
    Acne & Rosacea Review
    Tue, 01/11/2011 - 15:37

    Recent research, news and treatment trends.

    Study Assesses the Effectiveness of Low-dose and Intermittent Oral Isotretinoin in the Treatment of Acne

    While the efficacy of conventional isotretinoin treatment (0.5 to 1.0 mg/kg per day for 16 to 32 weeks, reaching a cumulative dose of 120mg/kg) for acne has been well established, there also are many reports regarding the efficacy of low-dose and intermittent isotretinoin treatment in acne patients.

    Read the full story
  • FDA Approvals and News
    News
    Thu, 12/09/2010 - 09:18

    AAD Announces Updated Position Statement on Isotretinoin

    Read the full story
  • Cover Story
    2010 Year in Review
    Wed, 12/08/2010 - 12:01

    A look at clinically relevant discoveries and cutting-edge breakthroughs in dermatology.

    The year 2010 has brought a vast array of exciting discoveries in the field of dermatology. This 2010 year-in-review article highlights clinically relevant discoveries and cutting-edge breakthroughs in select areas of dermatology, including: infectious disease, alopecia, acne, psoriasis, atopic dermatitis, contact dermatitis, pediatric dermatology, cutaneous malignancy, and cosmetic dermatology.

    Read the full story
  • Feature
    Locker Room Dermatoses
    Tue, 10/12/2010 - 11:05

    Whether or not they realize it, says this team dermatologist for the Baltimore Orioles, dermatologists who treat disorders such as folliculitis, verruca, actinic keratoses and cold urticaria, are practicing sports dermatology.

    Sports dermatology may sound more intimidating to the practitioner than it should. Just because you think you don’t know much about sports doesn’t mean you don’t practice “sports dermatology.”

    Read the full story
  • FDA Approvals and News
    FDA Approvals & News
    Mon, 09/13/2010 - 10:26

    News & Trends

    National Pest Management Association Confirms Bed Bug Infestations Rising

    A new survey conducted by the National Pest Management Association (NPMA) and the University of Kentucky, confirms that bed bug infestations are on the rise.

    The findings of the 2010 Comprehensive Global Bed Bug Study, which sought to determine the extent of the resurgence, are based on responses from nearly 1,000 U.S. and international pest management companies.

    Among them, 95% of U.S. survey respondents indicated that their company has encountered a bed bug infestation in the

    Read the full story
  • Cover Story, Feature
    Pediatric Dermatology Roundup
    Thu, 07/29/2010 - 14:22

    New developments and controversies in pediatric dermatology.

    Data on new approaches to dermatological conditions affecting children and issues surrounding their treatment have recently been topics in the news and at meetings. Two new treatments for infantile hemangiomas that may offer a much-needed alternative to systemic corticosteroids are propranolol, a non-selective beta-adrenergic antagonist, and Timolol gel, a topical non-selective beta-adrenergic antagonist. Benzyl alcohol lotion 5% has emerged as a new first-line treatment for head lice.

    Acne-related issues include the fa

    Read the full story
  • FDA Approvals and News
    FDA Approvals & News
    Thu, 07/29/2010 - 13:08

    Fougera Announces First Generic Approval of Adapalene Cream 0.1%

    E. Fougera & Co., announced it has received first generic approval from the FDA for adapalene cream 0.1%. According to the company, its adapalene cream 0.1% is rated AB, generically equivalent to the brand Differin. According to industry data, U.S. sales of the brand named product in 2009 exceeded $55 million. This approval also marks the fourth product approval that the FDA has granted to Fougera this year.

    “Fougera’s commitment to develop this first-to-market product as a cost-effective generic provides healthcar

    Read the full story